2020-2027 Analysis and Review Enzymatic Wound Debridement Market

Enzymatic Wound Debridement Market

Enzymatic Wound Debridement Market By Type (Acute Wounds, Chronic Wounds and Others), By Product (Papain, Collagenase and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020 – 2027

08-05-2020 REP-HC-5078 40 Tables 100 pages Format

The enzymatic wound debridement market was valued at USD 764.3 Mn by 2019. As per the latest research citings presented by the International Diabetes Federation (IDF), it is expected that by 2030 approximately 552.0 million people are going to suffer with diabetes throughout the globe. A significant increase in the number of surgeries performed worldwide further accentuates the enzymatic wound debridement market growth.

Enzymatic Wound Debridement Market

Enzymatic wound debridement is used for patients who cannot tolerate surgery and the wound site is relatively smaller. Papain is derived from the papaya fruit, collagenase form bacteria and deoxyribonucleases, and fibrinolysins from the bovine extracts. It is imperative to assess the wound before application of the wound debridement product or it might lead to skin sensitization and occurrence of vesiculation and erythema on the skin surface.

The major segments related to the enzymatic wound debridement market are: 

By Type (2017–2027; US$ Mn)

Active Wounds

Chronic Wounds

Others

By Product (2017–2027; US$ Mn)

Papain

Collagenase

Others

Geography Segment (2017–2027; US$ Mn)

North America

United States
Canada

Europe

United Kingdom
Germany
Russia
France
Italy
Spain
Ukraine
Rest of Europe

Asia Pacific

China
Japan
Rest of Asia Pacific

Latin America (LATAM)

Brazil
Mexico
Rest of Latin America

Middle East and Africa (MEA)

GCC
Rest of MEA 

Justification for study?

  • The intention of the study is to give a comprehensive outlook of the global enzymatic wound debridement market
  • The overall segmentation of the enzymatic wound debridement market, by type, product, and geography is minutely studied. Acute wounds and collagenase are dominating the type and product segments respectively
  • Rising prevalence of diabetic foot ulcers, pressure ulcers and venous ulcers worldwide
  • Significant increase in the number of traumatic accidents pertaining to vehicles and occupational hazards further accentuate the market growth

Report gist?

  • The study of the global enzymatic wound debridement market includes qualitative analysis of factors such as drivers, restraints, and opportunities
  • The report covers qualitative and quantitative analysis of the overall market segmented on the basis of type and product and categorization of the same at geography level
  • This research report presents the analysis of each segment from 2017 to 2027 in which 2019 is considered as the base year. Compounded annual growth rate is calculated for the respective segments from 2020 to 2027

The study includes the profiles of major market players with a significant global and regional presence along with top company positioning. 

Significant customers?

  • This study is suitable for industry participants and stakeholders in the pharmaceutical manufacturers actively engaged in the production and marketing of enzymatic wound debridement products to tend to acute and chronic wounds
  • The report will benefit hospital administrators engaged in the management of traumatic and medical emergency units in hospitals and clinics worldwide
  • Managers with financial institutions looking to publish recent and forecasted statistics pertaining to enzymatic wound debridement market
  • Financial institutions venture capitalist, analysts, investors, government organizations, policymakers, regulatory authorities, researchers, looking for insights into the market to determine future strategies 

Segment Analysis

Acute wounds are representing the largest market share in the type segment for enzymatic wound debridement market. Lacerations, burns, incisions, and punctures comprise acute wounds that are experienced by human beings at least once during their lifetime. Chronic wounds are estimated to register rampant market growth in the near future on account of a significant increase in the number of patients suffering from diabetic foot ulcers worldwide. A constant rise in the number of surgeries performed throughput the globe further propel its market growth. 

Collagenase is presently leading the product segment for enzymatic wound debridement market. It is frequently used owing to its ability to debride necrotic tissue, which prevents the accumulation of harmful tissue debris. Collagenase ointments help in the granulation process to promote epithelialization of skin cells. It helps in the transition of wounds from the inflammatory stage to the proliferative stage of wound healing. A significant increase in diabetic foot ulcers and pressure ulcers worldwide drives its market growth. Papain products are employed by the physicians for the treatment of large wounds accompanied by sepsis and cellulite. It is either used in combination with urea or saline solution depending on the degree of tissue necrosis at the wound site. Hydrogels have relatively high moisture content but they are not completely absorbent so they are widely used for tending wounds with light to moderate exudation. 

North America is presently dominating the geography segment for enzymatic wound debridement market. The chief factors responsible for its market growth are the rising prevalence of diabetic foot ulcers in the region. According to the American Diabetes Association (ADA), approximately 1.5 million Americans are diagnosed with diabetes each year. Additionally the domicile of key players such as Mölnlycke Health Care AB, Coloplast Corp., ConvaTec Group, Plc., Medline Industries, Inc., etc. further bolster the market growth in the region. Europe is considered as the second-largest regional segment on account of the supportive regulatory environment provided by the European Medical Agency for the sale and distribution of enzymatic wound debridement products to tend the wounds prevalent in the region. Asia Pacific is anticipated to be the fastest-growing regionals segment during the forecast period. Significant increase in the acute wounds associated with domestic accidents and constant rise in the chronic wounds associated with diabetic foot ulcers and pressure ulcers together drive the market growth in the Asia Pacific region.

Select License Type

$4,600
$6,600
$13,200

Safe and Secure SSL Encrypted

Have a Question?

We will help you find what you are looking for.

Call 1-518-730-1560

Contact sales

How can we help you?

Get in touch with us or find an office closest to you.